clopidogrel has been researched along with Thromboembolism, Venous in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, SS; Bauersachs, RM; Beckman, JA; Berkowitz, SD; Bonaca, MP; Bura-Rivière, A; Capell, WH; Debus, ES; Haskell, LP; Henkin, S; Hess, CN; Hsia, J; Lawall, H; Muehlhofer, E; Nehler, MR; Patel, MR; Piazza, G; Roztocil, K; Szarek, M | 1 |
| Bellomo, T; Boada, AE; Dua, A; Goudot, G; Hall, RP; Jessula, S; Kukreja, N; Lee, I; Majumdar, M; Parmar, G; Suarez Ferreira, SP | 1 |
| Dishy, V; Kobayashi, F; Kochan, J; Limsakun, T; McPhillips, P; Mendell, J; Orihashi, Y; Pav, J; Pizzagalli, F; Rambaran, C; Vandell, AG; Warren, V; Zhou, J | 1 |
| Georges, CJ; Li, RH; Lo, ST; Stern, JA; Walker, AL | 1 |
| Albaladejo, P; Kamphuisen, P; Llau, JV | 1 |
| Cao, L; Gui, K; Li, N; Wan, Z; Wang, Q; Xiong, M; Yan, W; Yang, C; Yang, R; Zhang, Y; Zhao, M; Zhu, Y | 1 |
| Bramlage, P; Diehm, C; Lawall, H; Oberacker, R; Schellong, SM; Zemmrich, C | 1 |
| Gentilomo, C; Huang, YS; Raffini, L | 1 |
| Carpio, A; Chae, YK; Gupta, S; Khemasuwan, D; Lucca, AB; Mora, JI; Neagu, S; Valsecchi, ME; Yun, JH | 1 |
1 trial(s) available for clopidogrel and Thromboembolism, Venous
| Article | Year |
|---|---|
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.
Topics: Aged; Aspirin; Clopidogrel; Cohort Studies; Female; Humans; Lower Extremity; Male; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Rivaroxaban; Venous Thromboembolism | 2022 |
8 other study(ies) available for clopidogrel and Thromboembolism, Venous
| Article | Year |
|---|---|
Atorvastatin Effect on Clopidogrel Efficacy in Patients with Peripheral Artery Disease.
Topics: Anticoagulants; Aspirin; Atorvastatin; Clopidogrel; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Treatment Outcome; Venous Thromboembolism | 2023 |
Safety and Pharmacokinetics of DS-1040 Drug-Drug Interactions With Aspirin, Clopidogrel, and Enoxaparin.
Topics: Administration, Oral; Adult; Area Under Curve; Aspirin; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clopidogrel; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Healthy Volunteers; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Venous Thromboembolism; Young Adult | 2020 |
Dual therapy with clopidogrel and rivaroxaban in cats with thromboembolic disease.
Topics: Animals; Anticoagulants; Cat Diseases; Cats; Clopidogrel; Humans; Retrospective Studies; Rivaroxaban; Venous Thromboembolism | 2022 |
European guidelines on perioperative venous thromboembolism prophylaxis: Chronic treatments with antiplatelet agents.
Topics: Anesthesiology; Anticoagulants; Aspirin; Blood Coagulation; Clopidogrel; European Union; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Incidence; Intermittent Pneumatic Compression Devices; Long-Term Care; Nerve Block; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Assessment; Risk Factors; Societies, Medical; Surgical Procedures, Operative; Time Factors; Venous Thromboembolism | 2018 |
Beraprost sodium versus clopidogrel for preventing vascular thromboembolic events of arteriovenous fistula in uraemic patients: a retrospective study with a mean 3-year follow-up.
Topics: Administration, Oral; Adult; Arteriovenous Fistula; Clopidogrel; Drug Administration Schedule; Epoprostenol; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Renal Dialysis; Retrospective Studies; Uremia; Venous Thromboembolism | 2019 |
Prevalence of deep vein thrombosis in acutely admitted ambulatory non-surgical intensive care unit patients.
Topics: Aged; Aged, 80 and over; Anticoagulants; APACHE; Aspirin; Clopidogrel; Female; Fibrin Fibrinogen Degradation Products; Germany; Heparin; Humans; Intensive Care Units; Male; Middle Aged; Outpatient Clinics, Hospital; Patient Admission; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Pulmonary Embolism; Risk Factors; Ticlopidine; Venous Thromboembolism; Venous Thrombosis | 2014 |
Significant increase in clopidogrel use across U.S. children's hospitals.
Topics: Adolescent; Child; Child, Preschool; Clopidogrel; Coronary Thrombosis; Databases, Factual; Drug Therapy, Combination; Female; Heart Defects, Congenital; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Inpatients; Length of Stay; Male; Mortality; Pediatrics; Platelet Aggregation Inhibitors; Poisson Distribution; Pulmonary Embolism; Retrospective Studies; Risk Assessment; Stroke; Ticlopidine; United States; Venous Thromboembolism | 2011 |
Dose-related effect of statins in venous thrombosis risk reduction.
Topics: Aged; Aspirin; Atherosclerosis; Cerebral Infarction; Clopidogrel; Cohort Studies; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pulmonary Embolism; Retrospective Studies; Risk Reduction Behavior; Ticlopidine; Venous Thromboembolism | 2011 |